Annual Report 2023

Management Discussion and Analysis 管理層討論與分析 16 Sunny Optical Technology (Group) Company Limited • ANNUAL REPORT 2023 光學儀器 在智能裝備業務方面，本集團圍繞工業智能裝 備、醫療裝備及新興市場裝備業務的需求， 充分發揮自身在光學成像和圖像處理算法等 技術方面的優勢，持續賦能先進製造。於回顧 年內，本集團完成手機芯片組件檢測設備的研 發。該設備採用高精度光學系統及自研 AI 模型 與傳統圖像算法相結合的方式，實現對缺陷的 高精度檢測，設備綜合效率及檢測性能處於行 業領先水平。 在顯微儀器業務方面，本集團把握醫療業務智 能化升級與進口替代趨勢，持續鑽研技術創 新，構建「名配角戰略」和「自主品牌」的市場優 勢，鞏固並擴大了顯微鏡、智能醫療掃描儀業 務的市場規模。於回顧年內，本集團已完成血 液形態學掃描儀的研發，並與一家血液檢測領 域頭部企業完成戰略合作並實現小批量交付。 該產品掃描速度和成像質量處於國產第一梯隊 水平。與此同時，本集團將循環腫瘤細胞掃描 儀的螢光拓展至五通道，支持明場與多通道螢 光一體成像，並將其成功拓展至海外市場。另 外，本集團與合作夥伴一同制定完成循環腫瘤 細胞診斷解決方案。該產品的成功表明本集團 在螢光成像領域技術的進步和領先地位以及在 高端顯微掃描儀市場具有較強大的核心競爭 力。除此之外，本集團創新突破了超長工作距 離半復消色差金相物鏡技術，並實現全系列物 鏡量產。該產品擁有國內最長工作距離，且可 實現高分辨率、高精度工業半導體領域的成像。 OPTICAL INSTRUMENTS In terms of the intelligent equipment business, with the focus on industrial intelligent equipment, medical equipment and the demand for equipment in emerging markets, the Group fully leveraged on its advantages in optical imaging, image processing algorithms and other technologies and continuously empowered advanced manufacturing. During the year under review, the Group completed the R&D of handset chip component inspection equipment, which adopted high precision optical system and the combination of self-developed AI models with traditional image algorithms to achieve high-precision inspection on defects, and is at the industry-leading position in overall efficiency and inspection performance of equipment. In terms of the microscopic instrument business, the Group seized the intelligent upgrading of the medical business and the trend of import substitution, continuously tapped into technological innovation, built the advantages of the “Mingpeijiao Strategy” ( 名配角戰略 ) and “self-owned brands”, consolidated and expanded the market size of the microscope and intelligent medical scanner business. During the year under review, the Group has completed the R&D of blood morphological scanners, participated in the strategic cooperation with a leading enterprise in the blood detection sector and achieved small batch delivery. The scanning speed and imaging quality of this product are in the first echelon in China. Meanwhile, the Group expanded the fluorescence for circulating tumour cell scanners to five channels to support the integrated imaging with fluorescence in light fields and various channels. It has successfully promoted this product to overseas markets. In addition, the Group and its partners formulated and completed solutions on the diagnosis of circulating tumor cells. The success of the product demonstrated the Group’s progress and leading position in fluorescence imaging technology, as well as its strong core competitiveness in the high-end microscopic scanner market. Besides, the Group made innovations and breakthroughs in the technology for semi-apochromatic metallurgical objectives with an ultra-long working distance and achieved the mass production of full series of objectives. Such product has the longest working distance in China and can achieve high-resolution and high-precision imaging in the industrial semiconductor sector.